• search
Discovery Chemistry Infrastructure Discovery Chemistry Infrastructure

Discovery Chemistry Infrastructure

Best-in class discovery chemistry services backed by state-of-the-art R and D center.

Our best-in-class discovery chemistry services are backed by state-of-the-art infrastructure. We handle a wide range of chemistry services across various platforms from our R and D center in Bangalore. The facility houses 300+ fume hoods with all essential instrumentation across 40 + modular labs.

Our facility has high-end equipments such as automated peptide synthesizers, liberty pro peptide synthesizers, microwave machines, combi-flash MPLC systems and oligo synthesizers. Also, our facility has state-of-the-art 3D virtual reality, high-performance computing ICM-Pro (MolSoft) comprehensive modeling platform.

Our analytical infrastructure is quite extensive with equipments such as:

LC-MS/MS Unique SPs for chiral separation Fourier Transform Infrared Spectroscopy (FTIR) PolarimeterSupercritical Fluid Chromatography (SFC)
Differential Scanning Calorimeter (DSC) High-Performance Liquid Chromatograph (HPLC) Bruker 400-Megahertz Nuclear Magnetic Resonance Mass-directed purification systemsMass spectrometer

We also have an in-house reagent collection with around 50,000 chemicals available in-house which enables quick-start to projects. Our library synthesis services are supported by equipment such as a 12-Port SPE vacuum manifold, vacuum concentrator and mass-directed purification systems.

In addition to the above, we have a proprietary compound management system, which is a niche server-based system that helps our customers manage inventory and allows smooth integration to biology services.

Speak to our Experts

Why meet us at CPHI Barcelona?

SEPTEMBER 04, 2023

Why meet us at CPHI Barcelona?

Discover the Opportunities: Visit Aurigene Pharmaceutical Services at CPHI BarcelonaThe Contract Research, Development and Manufacturing Organization (CRDMO) industry is a dynamic and rapidly evolving sector emerging as it plays a vital role in providing a wide range of services enabling drug companies to bring their products to market efficiently and effectively...

Read More
Immuno Oncology - Therapies and Challenges

Immuno Oncology - Therapies and Challenges

With more than 200 distinct cancer types recognized and steady increase in cancer incidence rates, the fight with cancer takes a new shape with each emerging decade. First was surgery, followed by radiotherapy and chemotherapy. The fourth one was targeted cancer therapeutics, also known as precision therapies. Precision therapies were established with the discove...

Read More
Anti-Infective Drug Discovery

Anti-Infective Drug Discovery

Objective & Challenges: Objective was to identify an optimized anti-bacterial lead molecule with in vivo efficacy in relevant infection models an acceptable safety profile, and a patentable series.      Challenge was to develop a more efficacious compound than the reference standard.Study design: Compounds were designed and synth...

Read More

Alternate end-game strategies towards Nirmatrelvir synthesis: Defining a continuous flow process for the preparation of an anti-COVID drug

2023

Scalable alternate end-game strategies for the synthesis of the anti-COVID drug molecule Nirmatrelvir (1,PF-07321332) have been described. The first involves a direct synthesis of 1 via amidation of the carboxylic acid 7 (suitably activated as a mixed anhydride with either pivaloyl chloride or T3P) with the ...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack